Functional Genomic Studies of Early Myogenic Differentiation

早期肌源分化的功能基因组研究

基本信息

项目摘要

The overall goal of this project is to employ a novel functional genomics approach to identify genes whose products induce the differentiation of mouse embryonic stem (ES) cells towards muscle cells. In Aim 1, a highly defective, non-cytotoxic HSV mutant will be developed that is deficient for expression of the immediate early (IE) genes and capable of replication in cells engineered to contain a vector-inducible, trans-complementing ICP4 gene. In Aim 2, a panel of mouse ES cell lines will be created in which either the EGFP or ICP4 gene will be recombined into the cellular genome juxtaposed to the promoter that drives expression of one of the muscle differentiation factors Pax7, myf5, or myoD. Using established culture conditions, the EGFP cell lines will be differentiated towards muscle cells and the appearance of fluorescing cells will be correlated with detection of stage specific myocytic markers. In Aim 3, the mutant virus will be engineered to contain a bacterial artificial chromosome and a recombination system, "Gateway" (Invitrogen), which will then be used to introduce a mouse muscle lprogenitor cell cDNA library into the vector. The vector library will be propagated in bacteria as single lcopy plasmids, its complexity established by quantitative PCR for low and medium copy genes and ltransfected into ICP4-complementing Vero cells for virus production. In Aim 4, pooled library vectors will lbe propagated on complementing Vero cells in microtiter wells and replica plated onto the three myogenic promoter-ICP4 ES cell lines. Progeny vector particles generated in cells expressing ICP4 by induction of the resident myogenic promoter will be isolated by limiting dilution on complementing Vero cells and rescreened on the panel of EGFP ES cell lines to determine whether the cellular factor is functional in activating early and late stage myogenic factor promoters. The cDNA of activating vectors will be sequenced, compared with known data bases for preliminary assessment of function and further characterized for their ability to induce muscle cell markers using immunological and biochemical assays. Ultimately, we hope to identify novel factors or signaling mechanisms that interact to control early muscle cell development.
该项目的总体目标是采用一种新颖的功能基因组学方法来识别基因 其产品诱导小鼠胚胎干(ES)细胞向肌肉细胞分化。在 目标 1,将开发一种高度缺陷的、非细胞毒性的 HSV 突变体,其表达缺陷 即刻早期 (IE) 基因,能够在经过改造的细胞中复制 载体诱导型、反式互补 ICP4 基因。在目标 2 中,将创建一组小鼠 ES 细胞系 其中 EGFP 或 ICP4 基因将被重组到与 驱动肌肉分化因子 Pax7、myf5 或 myoD 之一表达的启动子。使用 在建立的培养条件下,EGFP细胞系将分化为肌肉细胞和 荧光细胞的出现将与阶段特异性肌细胞标记物的检测相关。在 目标 3,突变病毒将被设计为包含一条细菌人工染色体和一条 重组系统“Gateway”(Invitrogen),然后将用于引入小鼠肌肉 l 将祖细胞cDNA文库导入载体中。载体库将作为单个载体在细菌中繁殖 lcopy质粒,其复杂性是通过低拷贝和中拷贝基因的定量PCR确定的 l 转染至 ICP4 互补的 Vero 细胞中用于病毒生产。在目标 4 中,汇集的文库载体将 LBE 在微量滴定孔中的补充 Vero 细胞上繁殖,并将复制品铺在三个生肌细胞上 启动子-ICP4 ES细胞系。通过诱导在表达 ICP4 的细胞中产生子代载体颗粒 通过补充 Vero 细胞的有限稀释来分离驻留的生肌启动子,并且 对 EGFP ES 细胞系进行重新筛选,以确定细胞因子是否在 激活早期和晚期生肌因子启动子。激活载体的cDNA为 测序,与已知数据库进行比较以初步评估功能并进一步 其特点是能够使用免疫学和生化测定诱导肌肉细胞标记。 最终,我们希望识别出相互作用以控制早期肌肉的新因素或信号机制 细胞发育。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Joseph C Glorioso其他文献

EFFECTS OF HERPES SIMPLEX VIRUS VECTOR-MEDIATED ENKEPHALIN GENE THERAPY ON BLADDER OVERACTICITY AND NOCICEPTION
  • DOI:
    10.1016/s0022-5347(09)60069-0
  • 发表时间:
    2009-04-01
  • 期刊:
  • 影响因子:
  • 作者:
    Hitoshi Yokoyama;Chikashi Saitoh;Minoru Miyazato;Osamu Nishizawa;Michael B Chancellor;William F Goins;James R Goss;Joseph C Glorioso;Naoki Yoshimura
  • 通讯作者:
    Naoki Yoshimura
EFFECTS OF DIFFERENT ENKEPHALIN TREATMENTS ON BLADDER PAIN
  • DOI:
    10.1016/s0022-5347(08)60177-9
  • 发表时间:
    2008-04-01
  • 期刊:
  • 影响因子:
  • 作者:
    Hitoshi Yokoyama;Chikashi Saitoh;Minoru Miyazato;Osamu Nishizawa;Michael B Chancellor;William F Goins;James R Goss;Joseph C Glorioso;Naoki Yoshimura
  • 通讯作者:
    Naoki Yoshimura
871 EFFECT OF HERPES SIMPLEX VIRUS (HSV) VECTOR-MEDIATED INTERLEUKIN 4 GENE THERAPY ON ENHANCED BLADDER PAIN BEHAVIOR IN RATS WITH CYCLOPHOSPHAMIDE (CYP)-INDUCED CYSTITIS
  • DOI:
    10.1016/j.juro.2013.02.440
  • 发表时间:
    2013-04-01
  • 期刊:
  • 影响因子:
  • 作者:
    Tomohiko Oguchi;Hitoshi Yokoyama;Yasuhito Funahashi;Osamu Nishizawa;Satoru Yoshikawa;William F Goins;James R Goss;Joseph C Glorioso;Naoki Yoshimura
  • 通讯作者:
    Naoki Yoshimura
Viral vectors for gene therapy: the art of turning infectious agents into vehicles of therapeutics
用于基因治疗的病毒载体:将感染因子转化为治疗载体的艺术
  • DOI:
    10.1038/83324
  • 发表时间:
    2001-01-01
  • 期刊:
  • 影响因子:
    50.000
  • 作者:
    Mark A. Kay;Joseph C Glorioso;Luigi Naldini
  • 通讯作者:
    Luigi Naldini

Joseph C Glorioso的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Joseph C Glorioso', 18)}}的其他基金

Arming Oncolytic HSV Vectors to Induce Anti-GBM Immune Responses in Syngeneic Mice
武装溶瘤 HSV 载体在同基因小鼠中诱导抗 GBM 免疫反应
  • 批准号:
    9927607
  • 财政年份:
    2018
  • 资助金额:
    $ 31.67万
  • 项目类别:
Arming Oncolytic HSV Vectors to Induce Anti-GBM Immune Responses in Syngeneic Mice
武装溶瘤 HSV 载体在同基因小鼠中诱导抗 GBM 免疫反应
  • 批准号:
    10409654
  • 财政年份:
    2018
  • 资助金额:
    $ 31.67万
  • 项目类别:
Project 1: Arming Oncolytic HSV Vectors to Improve Virolysis in Syngeneic Mouse Models of GBM
项目 1:武装溶瘤 HSV 载体以改善 GBM 同基因小鼠模型中的病毒溶解
  • 批准号:
    10019362
  • 财政年份:
    2013
  • 资助金额:
    $ 31.67万
  • 项目类别:
Project 1: Arming Oncolytic HSV Vectors to Improve Virolysis in Syngeneic Mouse Models of GBM
项目 1:武装溶瘤 HSV 载体以改善 GBM 同基因小鼠模型中的病毒溶解
  • 批准号:
    10491206
  • 财政年份:
    2013
  • 资助金额:
    $ 31.67万
  • 项目类别:
Project 1: Arming Oncolytic HSV Vectors to Improve Virolysis in Syngeneic Mouse Models of GBM
项目 1:武装溶瘤 HSV 载体以改善 GBM 同基因小鼠模型中的病毒溶解
  • 批准号:
    10251082
  • 财政年份:
    2013
  • 资助金额:
    $ 31.67万
  • 项目类别:
Project 1: Treatment of GBM using an oncolytic HSV engineered to improve immunogenic tumor destruction
项目 1:使用经过改造的溶瘤 HSV 治疗 GBM,以改善免疫原性肿瘤破坏
  • 批准号:
    10712280
  • 财政年份:
    2013
  • 资助金额:
    $ 31.67万
  • 项目类别:
Glycine Receptor Expression in Sensory Afferents to Modulate Pain Signaling
感觉传入中甘氨酸受体的表达调节疼痛信号传导
  • 批准号:
    8309978
  • 财政年份:
    2011
  • 资助金额:
    $ 31.67万
  • 项目类别:
Glycine Receptor Expression in Sensory Afferents to Modulate Pain Signaling
感觉传入中甘氨酸受体的表达调节疼痛信号传导
  • 批准号:
    8186007
  • 财政年份:
    2011
  • 资助金额:
    $ 31.67万
  • 项目类别:
Glycine Receptor Expression in Sensory Afferents to Modulate Pain Signaling
感觉传入中甘氨酸受体的表达调节疼痛信号传导
  • 批准号:
    8703184
  • 财政年份:
    2011
  • 资助金额:
    $ 31.67万
  • 项目类别:
Glycine Receptor Expression in Sensory Afferents to Modulate Pain Signaling
感觉传入中甘氨酸受体的表达调节疼痛信号传导
  • 批准号:
    8520405
  • 财政年份:
    2011
  • 资助金额:
    $ 31.67万
  • 项目类别:

相似海外基金

Co-designing a lifestyle, stop-vaping intervention for ex-smoking, adult vapers (CLOVER study)
为戒烟的成年电子烟使用者共同设计生活方式、戒烟干预措施(CLOVER 研究)
  • 批准号:
    MR/Z503605/1
  • 财政年份:
    2024
  • 资助金额:
    $ 31.67万
  • 项目类别:
    Research Grant
Early Life Antecedents Predicting Adult Daily Affective Reactivity to Stress
早期生活经历预测成人对压力的日常情感反应
  • 批准号:
    2336167
  • 财政年份:
    2024
  • 资助金额:
    $ 31.67万
  • 项目类别:
    Standard Grant
RAPID: Affective Mechanisms of Adjustment in Diverse Emerging Adult Student Communities Before, During, and Beyond the COVID-19 Pandemic
RAPID:COVID-19 大流行之前、期间和之后不同新兴成人学生社区的情感调整机制
  • 批准号:
    2402691
  • 财政年份:
    2024
  • 资助金额:
    $ 31.67万
  • 项目类别:
    Standard Grant
Elucidation of Adult Newt Cells Regulating the ZRS enhancer during Limb Regeneration
阐明成体蝾螈细胞在肢体再生过程中调节 ZRS 增强子
  • 批准号:
    24K12150
  • 财政年份:
    2024
  • 资助金额:
    $ 31.67万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Migrant Youth and the Sociolegal Construction of Child and Adult Categories
流动青年与儿童和成人类别的社会法律建构
  • 批准号:
    2341428
  • 财政年份:
    2024
  • 资助金额:
    $ 31.67万
  • 项目类别:
    Standard Grant
Understanding how platelets mediate new neuron formation in the adult brain
了解血小板如何介导成人大脑中新神经元的形成
  • 批准号:
    DE240100561
  • 财政年份:
    2024
  • 资助金额:
    $ 31.67万
  • 项目类别:
    Discovery Early Career Researcher Award
RUI: Evaluation of Neurotrophic-Like properties of Spaetzle-Toll Signaling in the Developing and Adult Cricket CNS
RUI:评估发育中和成年蟋蟀中枢神经系统中 Spaetzle-Toll 信号传导的神经营养样特性
  • 批准号:
    2230829
  • 财政年份:
    2023
  • 资助金额:
    $ 31.67万
  • 项目类别:
    Standard Grant
Usefulness of a question prompt sheet for onco-fertility in adolescent and young adult patients under 25 years old.
问题提示表对于 25 岁以下青少年和年轻成年患者的肿瘤生育力的有用性。
  • 批准号:
    23K09542
  • 财政年份:
    2023
  • 资助金额:
    $ 31.67万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Identification of new specific molecules associated with right ventricular dysfunction in adult patients with congenital heart disease
鉴定与成年先天性心脏病患者右心室功能障碍相关的新特异性分子
  • 批准号:
    23K07552
  • 财政年份:
    2023
  • 资助金额:
    $ 31.67万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Issue identifications and model developments in transitional care for patients with adult congenital heart disease.
成人先天性心脏病患者过渡护理的问题识别和模型开发。
  • 批准号:
    23K07559
  • 财政年份:
    2023
  • 资助金额:
    $ 31.67万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了